Central retinal vein occlusion: modifying current treatment protocols.
about
Real-world outcomes of anti-VEGF treatment for retinal vein occlusion in Portugal.Comparison between "early" or "late" intravitreal injection of dexamethasone implant in branch (BRVO) or central (CRVO) retinal vein occlusion: six-months follow-up.Comment on: 'Central retinal vein occlusion: modifying current treatment protocols'.Factor V G1691A is associated with an increased risk of retinal vein occlusion: a meta-analysis.Outcomes of switching treatment to aflibercept in patients with macular oedema secondary to central retinal vein occlusion refractory to ranibizumab.
P2860
Central retinal vein occlusion: modifying current treatment protocols.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Central retinal vein occlusion: modifying current treatment protocols.
@ast
Central retinal vein occlusion: modifying current treatment protocols.
@en
type
label
Central retinal vein occlusion: modifying current treatment protocols.
@ast
Central retinal vein occlusion: modifying current treatment protocols.
@en
prefLabel
Central retinal vein occlusion: modifying current treatment protocols.
@ast
Central retinal vein occlusion: modifying current treatment protocols.
@en
P2860
P356
P1433
P1476
Central retinal vein occlusion: modifying current treatment protocols
@en
P2093
A A R Souka
P2860
P2888
P304
P356
10.1038/EYE.2016.10
P577
2016-02-12T00:00:00Z